Anuncia, a medical device company and innovator in cerebrospinal fluid (CSF) management, announced its plan to move its headquarters to Scottsdale.

The headquarters will be at SkySong, the Arizona State University Scottsdale Innovation Center. This location provides the company with access to research and development opportunities, as well as bioscience and healthcare talent. It also allows collaboration opportunities with local universities on new medical technologies that deliver safe and effective therapy to patients who suffer from life threatening conditions, like CSF disorders.

The relocation, which is the first geographic expansion for the Massachusetts-based company, will also bring a new management team of industry experts, who will engineer intuitive solutions that address unmet clinical needs.

Anuncia developed the ReFlow Ventricular System, which is used to relieve pressure on the brain cause by CSF. The ReFlow Mini earned the FDA Breakthrough Device Designation earlier this year, as well as an honorable mention in the health category of Fast Company’s World Changing Ideas of 2021.

To read more, click here.